Marco Carbone

Liver Physician and Associate Professor @unimib & @ospniguarda Special interest in autoimmune liver diseases

[Marco Carbone @MCarbone_80]

Thrilled to see this major milestone in #PBC !

FDA, patients, global KOL come together in this
@AASLDtweets & @EASLedu consensus to define the path forward for drug registration.
Hats off to @analleo &@CLevy for driving this.
@ospniguarda @unimib

https://t.co/iRRvWH3zDT

[Ospedale Niguarda @ospniguarda]

L’Ospedale Niguarda di Milano nella “World’s Best Specialized Hospitals 2026”, la classifica internazionale delle migliori specialità ospedaliere
https://t.co/2X5FHWXlVO

[Marco Carbone @MCarbone_80]

Fun chat on #EASLStudio with pharma colleagues about developing new compounds in #PBC and the path toward the @EASLedu /@AASLDtweets consensus.@ospniguarda @unimib

[EASLnews @EASLnews]

This week's EASL Studio is now available on demand! Learn from our faculty as they discuss biochemical and imaging-based endpoints in primary biliary cholangitis.

Watch here: https://t.co/4njMfWRhFS

@MCarbone_80

#LiverTwitter #LiverX

[EASLnews @EASLnews]

The EASL Studio is back! Tune in this Wednesday 18:00 CEST as the faculty explore the relevance of alkaline phosphatase response, non-invasive fibrosis assessment, and composite scores like GLOBE and UK-PBC.

Read more: https://t.co/J4tYXhnwc2

@MCarbone_80 @FrancqueSven

#LiverTwitter #LiverX

[EASL Education @EASLedu]

📺 #EASLStudio your favourite hepatology broadcast news is back next week!🥳

Tune in Wednesday, 10 September at 18:00 to exploring ALP response, non-invasive fibrosis tools, and scores like GLOBE & UK-PBC shaping the future of #PBC care.
🔗https://t.co/UOpwkCRZBx

#LiverX

[Miki Scaravaglio @MScaravaglio]

Wondering whether your cholestatic patient might benefit from genetic testing and which genes to include? 🧬

Check out this paper 👉🏼 https://t.co/ytyyKdvrAE

Grateful to our patients and the incredible team Luisa Ronzoni @lalicristos @MCarbone_80 @lucavalenti75
#LiverTwitter

[Fabio Del Zompo @FDelZompo_MD]

Excited to share that our paper about Claudin-1 in primary sclerosing cholangitis is now published in the @JHepatology!
Grateful to family, mentors, @LiverStrasbourg staff, and collaborators!

Check it out at https://t.co/5apcwmD0uL

[Tom Hemming Karlsen @tomhemmingk]

From genetic associations to environmental triggers in PSC. Our EBV-paper is out in @NatureMedicine today. https://t.co/MpuN6fh790

[EASL Education @EASLedu]

@EASLnews @MCarbone_80 @EmmaCulver6 @LiverNotFighter @PBCFoundation @analleo @KeitelVerena @JesusMBanales @FrancqueSven @JHepatology #AIH or #DILI? A steroid trial can help guide the diagnosis.
👉But remission in AIH isn’t just biochemical. Clinical and histological remission matter too!
👉Patients in biochemical remission show better long-term outcomes.
@EASLnews
#EASLcongress

[EASL Education @EASLedu]

@EASLnews @MCarbone_80 @EmmaCulver6 @LiverNotFighter @PBCFoundation @analleo @KeitelVerena @JesusMBanales @FrancqueSven @JHepatology @Yujun__Wong @Apichatka Who's ready for #AIH immunosuppression withdrawal?
✔️ Stable remission on monotherapy (≥2 yrs)
🧪 ALT & IgG levels at withdrawal matter
📉 Lower ALT/IgG = better odds of remission
🧠 MRI cT1 adds insight beyond biochemistry

@EASLNews
#EASLCongress

[EASL Education @EASLedu]

👩‍⚕️ ERCP (endoscopic retrograde cholangiopancreatography) in PSC - when, how and by whom

When?
- Possible dominant or relevant stricture(s) on MRC
- Suspicion on neoplasia
- To slow down disease progression (?)

How?
- Always sample from possible DS
- In case of equivocal cytology new ERC with histology
- Initial treatment preferably by balloon dilatation

By whom?
- Expert endoscopist in consultation with expert radiologist

@EASLNews @MCarbone_80 @EmmaCulver @LiverNotFighter @PBCFoundation @KeitelVerena @FrancqueSven @analleo @JesusMBanales

#EASLCongress #PSC #LiverTwitter

[EASL Education @EASLedu]

🧲 MRI in PSC management

Beyond standard MRI, tools like MRE, Anali score, MRCP+, and DiStrict score help assess fibrosis and disease activity with more precision.

🤝 Close collaboration between hepatology and radiology is essential

@EASLNews @MCarbone_80 @EmmaCulver @LiverNotFighter @PBCFoundation @KeitelVerena @FrancqueSven @analleo @JesusMBanales

#EASLCongress #PSC #LiverTwitter

[EASL Education @EASLedu]

🧪 PSC diagnosis and monitoring challenges

ALP is widely used but has also a broad variation across patients.

👉🏽 ELF test and elastography are promising tools for prognosis - highlighted in the EASL CPGs on PSC: https://t.co/raMPcfQpLG

@EASLNews @MCarbone_80 @EmmaCulver @LiverNotFighter @PBCFoundation @KeitelVerena @FrancqueSven @analleo @JesusMBanales
#EASLCongress #PSC #LiverTwitter

[Tom Hemming Karlsen @tomhemmingk]

A special day for PSC. One phase II (in @JHepatology below, elafibranor) and one phase III (nor-UDCA, presented at the #EASLCongress) trial with potentially positive efficacy signals. Great inspiration. https://t.co/oW9YP6OF2Z

[Ospedale Niguarda @ospniguarda]

Ospedale Niguarda di Milano è il miglior ospedale italiano riconosciuto anche a livello mondiale, secondo la classifica di Newsweek
⤵️
https://t.co/kJo7sGZ6LM

[AISF - Associazione Italiana Studio Fegato @AisfFegato]

Il Dott. @MCarbone_80 ospite di Terzo Millennio Salute su Gold TV intervistato da @seta_daniel ha spiegato quali sono le priorità in tema di #malattierare e #malattieautoimmuni del fegato.

Dal min. 13.40

https://t.co/3DyUomzMH6

[PeerVoice @PeerVoice]

Best practices in tracking treatment response and targeting contemporary goals of care for patients with primary biliary cholangitis (PBC): Get expert insights in seven new streaming episodes. #PeerVoice #meded #hepatology #gastroenterology

https://t.co/hUhjKbRakF

[EASLnews @EASLnews]

In today's #readoftheweek📚 learn about the ALNE model and how it generates quantitative and accurate differential diagnosis between cases with AIH or PBC.

Read here this @JHEP_Reports article: https://t.co/Cnl97g5AkV

🙏@AlessioGerussi @BastianEngel @lalicristos @fe_mali @F__Colapietro @analleo @Calvar1Vincenza @DinaTiniakos @VLimperioMD @MCarbone_80 @jnkath et al.

#LiverTwitter #LiverX

[Vincenza Calvaruso @Calvar1Vincenza]

Autoimmune Liver Disease Days. Italian Autoimmune Liver Disease Clinical Research Network (IT-AILD CRN).
#itaild #liver
@AisfFegato

[AISF - Associazione Italiana Studio Fegato @AisfFegato]

I temi scientifici con i Prof. @AghemoAlessio, @salvatore_petta, @lucavalenti75, @MCarbone_80, @GIUSEPPECABIBBO, Quirino Lai.
Epatiti Virali, Steatosi, Epatopatia Alcolica, Malattie Rare, Autoimmuni e Colestatiche, Cirrosi, Epatocarcinoma, Trapianto di Fegato.
#LibroBiancoAISF